Lab result explainedThyroidLast updated November 10, 2026

Thyroglobulin antibodies: what a high thyroglobulin antibody level means

Thyroglobulin antibodies (TgAb) · Thyroid antibodies (ordered with TSH, free T4 and often TPO antibodies; with thyroglobulin in thyroid cancer follow-up) · reported in IU/mL (some reports use U/mL or kIU/L, which are equivalent)

Thyroglobulin antibodies (TgAb, anti-thyroglobulin) are antibodies against thyroglobulin, the large protein that thyroid cells use to build and store thyroid hormone. They are one of the two standard thyroid autoantibodies, alongside thyroid peroxidase (TPO) antibodies, and a positive result means the immune system is reacting against the thyroid: about 60 to 80 percent of people with Hashimoto's thyroiditis and 50 to 70 percent with Graves' disease have them. Roughly 10 percent of healthy adults are also positive, most with a normal TSH, so a positive test is a signal to check thyroid function rather than a diagnosis in itself.

The reference range is one of the least standardised of any common test. Depending on which manufacturer's assay your lab uses, negative may be under 4 IU/mL, under 20, under 40 or under 115 IU/mL, and the numbers are not interchangeable between labs. This matters most for the second, quite different use of the test: in people treated for papillary or follicular thyroid cancer, thyroglobulin is the tumor marker used to detect recurrence, and TgAb interferes with that measurement. For this reason TgAb is measured every time thyroglobulin is, on the same assay, and in antibody-positive patients the trend in the antibody itself becomes the surrogate marker.

The two uses cause most of the confusion around this test. If you were tested for tiredness, a goiter or an abnormal TSH, a positive TgAb is read like a positive TPO antibody: a marker of autoimmune thyroid disease with a modestly raised long-term risk of hypothyroidism. If you were tested after thyroid surgery for cancer, the question is not whether it is positive but whether it is falling, stable or rising over time. This page covers both, and makes clear which numbers belong to which situation.

TgAb at a glance

What it is: an antibody against thyroglobulin, the hormone-storage protein of the thyroid; a marker of autoimmune thyroid disease and an interfering factor in thyroid cancer follow-up.
Normal: below the assay cut-off, which ranges from under 4 IU/mL to under 115 IU/mL depending on the manufacturer; use the range on your own report.
Positive with a normal TSH: autoimmune thyroiditis without hypothyroidism; isolated TgAb (TPO negative) carries a lower risk of progression than TPO antibodies do.
Positive with a high TSH: Hashimoto's thyroiditis; positive with a low TSH: consistent with Graves' disease, confirmed by TSH receptor antibodies.
After thyroid cancer treatment: a positive TgAb makes the thyroglobulin result unreliable; a falling TgAb is reassuring, a rising one is investigated as possible recurrence.
Next step: TSH and free T4 now; TPO antibodies if not already done; for thyroid cancer, TgAb and thyroglobulin together every 6 to 12 months on the same assay.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What TgAb measures

Thyroglobulin is a 660-kilodalton glycoprotein made only by thyroid follicular cells. It fills the colloid at the center of each follicle, where thyroid peroxidase attaches iodine to it; the finished hormones T4 and T3 are then cut out of the thyroglobulin backbone and released. Because thyroglobulin is normally sealed inside the follicle, the immune system is not tolerant of it, and when autoimmune inflammation or thyroid injury exposes it, B cells can produce antibodies against it.

The lab measures TgAb with an immunoassay reported in IU/mL and calibrated against an international reference preparation, but different assays recognize different parts of the thyroglobulin molecule, which is why their cut-offs vary so widely and why a value from one lab cannot be compared with a value from another. For thyroid cancer follow-up, guidelines stress keeping the same assay over time for both TgAb and thyroglobulin.

The interference works like this: most modern thyroglobulin assays sandwich the protein between two antibodies, and a patient's own TgAb binding the protein blocks that sandwich, producing a falsely low or undetectable thyroglobulin. A thyroglobulin of 'less than 0.1 ng/mL' therefore means nothing if TgAb is present. Antibodies fall slowly once all thyroid tissue, benign or malignant, is gone, with a half-life of around 10 weeks and disappearance taking a median of about three years, so the direction of travel is the useful information.

Normal range for TgAb

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

Group	Typical range (IU/mL (some reports use U/mL or kIU/L, which are equivalent))	Notes
Negative (normal)	Below the assay cut-off: under 4 IU/mL, under 20, under 40 or under 115 IU/mL depending on the manufacturer	The widest cut-off variation of any routine thyroid test. Compare only with the range printed on your report.
Borderline or weakly positive	Just above the cut-off to roughly 2 to 3 times the cut-off	Can be early autoimmunity or assay noise; with a normal TSH it is usually just followed with TSH in 6 to 12 months.
Clearly positive	Several times the cut-off to many hundreds of IU/mL	Typical of Hashimoto's or Graves' disease. The level does not measure thyroid function.
Strongly positive	Above 1,000 IU/mL (assays differ in their upper reporting limit)	Common in long-standing Hashimoto's; not more dangerous than a lower positive value.
General population	About 10–12 percent of US adults are positive; women more often than men	Rises with age; many have a normal TSH and never develop thyroid disease.
Thyroid cancer follow-up, antibody-positive patient	Any detectable TgAb makes the thyroglobulin result unreliable	Followed by the trend: falling by at least half over 1 to 2 years is reassuring; a rise of 50 percent or more, or new appearance after being negative, prompts imaging.
Thyroid cancer follow-up, antibody-negative patient	Negative	Thyroglobulin can then be trusted as the tumor marker; TgAb is still re-measured with each thyroglobulin because antibodies occasionally appear later.

High (positive) thyroglobulin antibodies

Outside thyroid cancer follow-up, a positive TgAb means autoimmune thyroid disease, exactly as a positive TPO antibody does. With a raised TSH it confirms Hashimoto's thyroiditis as the cause; with a low TSH it supports Graves' disease (the TSH receptor antibody is the specific test); with a normal TSH it describes autoimmune thyroiditis that has not affected thyroid output. TgAb is a little less sensitive and specific for Hashimoto's than TPO antibodies, and when TgAb is positive on its own with TPO negative, the link to future hypothyroidism is weaker: in population studies, isolated TgAb positivity carried only a small increase in risk, whereas TPO positivity carried most of it.

After surgery for differentiated thyroid cancer, the meaning changes. About 20 to 25 percent of thyroid cancer patients have TgAb, roughly twice the rate in the general population, probably because the tumor or coexisting Hashimoto's exposes the antigen. In these patients the thyroglobulin result cannot be trusted and the antibody level itself is followed. Antibodies that fall steadily and eventually disappear indicate that all thyroglobulin-producing tissue is gone. Antibodies that plateau at a high level, rise by more than 50 percent between measurements, or reappear after becoming negative are treated as a possible sign of persistent or recurrent disease and prompt a neck ultrasound and sometimes other imaging.

In both settings the absolute number matters less than people expect. Assays differ so much that 30 IU/mL is strongly positive on one and negative on another, and within one assay the level can drift by 20 to 30 percent between draws for no reason. For autoimmune disease the test answers a yes-or-no question; for cancer follow-up it answers a direction-of-travel question, and only when the same assay is used each time.

Common causes

Hashimoto's thyroiditis
Present in 60 to 80 percent of patients, usually together with TPO antibodies. TgAb tends to be the first antibody to appear in some people and is positive in a share of those with TPO-negative Hashimoto's.
Graves' disease
Positive in 50 to 70 percent of patients alongside the TSH receptor antibodies that drive the overactivity; the level does not predict the course of Graves' disease.
Autoimmune thyroiditis without thyroid dysfunction
About one in ten adults, mostly women, carries TgAb with a normal TSH. Isolated TgAb (with TPO negative) carries only a small increase in the risk of later hypothyroidism.
Differentiated thyroid cancer (papillary or follicular)
Found in 20 to 25 percent of patients at diagnosis. The cancer itself does not make the antibody; the immune response to exposed thyroglobulin or coexisting lymphocytic thyroiditis does. Persistent or rising TgAb after treatment is a surrogate sign of remaining thyroid tissue or tumor.
Postpartum thyroiditis and subacute thyroiditis
Both release thyroglobulin from damaged follicles and can produce TgAb that persists for months; a test repeated a year later shows whether it was transient.
Thyroid nodules and multinodular goiter
Benign nodular disease is associated with low-level TgAb in a minority of patients, probably reflecting coexisting lymphocytic thyroiditis in the surrounding gland.
Other autoimmune diseases
Type 1 diabetes, celiac disease, pernicious anemia, Addison's disease, Sjögren's syndrome and lupus raise the chance of TgAb, which is often found during screening in these groups.
Excess iodine and thyroid-affecting drugs
High iodine intake, amiodarone, lithium, interferon-alpha and immune checkpoint inhibitors can induce thyroid autoimmunity, with TgAb appearing during or after exposure.
Older age and female sex
Prevalence rises steadily through adult life; women over 60 have the highest rates. In this group, a positive result with a normal TSH is common and often of no consequence.

Symptoms that can go with it

Often none: most people with positive thyroglobulin antibodies and a normal TSH feel well
If hypothyroidism has developed: fatigue, cold intolerance, weight gain, constipation, dry skin and hair, heavy periods, low mood
A painless, firm swelling at the front of the neck (goiter)
If Graves' disease: weight loss, heat intolerance, palpitations, tremor, anxiety, eye changes
After thyroid cancer treatment: usually no symptoms; recurrence is more often found on blood tests or ultrasound than felt, though a new neck lump, hoarseness or difficulty swallowing should always be reported
Symptoms of linked autoimmune conditions, such as tingling (B12 deficiency), bloating and diarrhea (celiac disease), or dizziness and salt craving (adrenal insufficiency)

Negative or low thyroglobulin antibodies

A negative TgAb is the normal result and has no medical significance on its own; there is no level that is 'too low'. For someone being investigated for thyroid disease, a negative TgAb and negative TPO antibody make autoimmune thyroiditis unlikely but not impossible, since 5 to 10 percent of people with Hashimoto's on ultrasound or biopsy are negative for both. For someone with an abnormal TSH and negative antibodies, other causes are considered: past surgery or radioiodine, medications, iodine deficiency or excess, or a pituitary cause.

After thyroid cancer treatment, a negative TgAb is good news for a different reason: it means the thyroglobulin result can be trusted as the tumor marker. In a patient who was previously TgAb-positive, a fall to negative is one of the most reassuring findings in follow-up, because it implies that the thyroglobulin that was driving the antibody response is no longer present. TgAb is still re-measured with every thyroglobulin test afterwards, because antibodies occasionally reappear and would make a later thyroglobulin unreliable.

Common causes

Normal, with no thyroid autoimmunity
The expected result in about 88 to 90 percent of adults. It does not need repeating unless a thyroid problem develops.
Hashimoto's with TPO antibodies only
Many people with Hashimoto's are TPO-positive and TgAb-negative; the diagnosis stands on the TPO result.
Seronegative autoimmune thyroiditis
A minority of people with lymphocytic thyroiditis on ultrasound or biopsy have neither antibody; ultrasound appearance and TSH guide management.
Successful thyroid cancer treatment
Once all thyroid tissue is removed or ablated, antibodies fall with a half-life of around 10 weeks and typically become undetectable within a few years.
Assay cut-off differences
A value of 30 IU/mL is negative on an assay with a cut-off of 115 and positive on one with a cut-off of 4; the printed range decides.

Symptoms that can go with it

None; a negative result causes no symptoms
If you have thyroid symptoms with negative antibodies, the symptoms still need an explanation; the negative result only narrows the cause

Read it alongside

TPO antibodies — the more sensitive autoantibody; the two are usually ordered together, and a positive TPO carries most of the risk of future hypothyroidism.
TSH — tells you whether the thyroid is actually underactive or overactive; antibodies alone do not.
Free T4 — low with a high TSH confirms overt hypothyroidism; high with a low TSH confirms hyperthyroidism.
Thyroglobulin — the tumor marker after thyroid cancer surgery; only interpretable when TgAb is negative, and always measured with it on the same assay.
TSH receptor antibodies (TRAb or TSI) — the specific test for Graves' disease when TSH is low.
Free T3 — useful in characterising hyperthyroidism; rarely needed in hypothyroidism.
Calcium — checked after thyroid surgery because the parathyroid glands can be bruised or removed.
tTG-IgA — celiac screening, because celiac disease coexists with autoimmune thyroid disease in 2 to 5 percent and impairs levothyroxine absorption.

What usually happens next

If you were tested for thyroid symptoms or an abnormal TSH: the next steps depend on TSH and free T4, not on the antibody. Normal TSH means a recheck in 6 to 12 months; TSH over 10 mIU/L or a low free T4 usually means levothyroxine.
If TgAb is positive but TPO antibodies are negative with a normal TSH, expect watchful waiting; this pattern carries a lower progression risk than TPO positivity and does not need treatment.
If you have had surgery for thyroid cancer: ask that TgAb and thyroglobulin are measured together, on the same assay each time, typically every 6 to 12 months, and ask whether your antibody trend is falling, stable or rising.
A rising TgAb after cancer treatment (more than 50 percent between tests, or reappearance after being negative) is usually followed by a neck ultrasound and, depending on findings, a radioiodine scan or other imaging; a rise is a prompt to look, not proof of recurrence.
If you are pregnant or planning pregnancy with positive antibodies: ask for TSH in each trimester and a TSH at 3 and 6 months after delivery.
Avoid comparing results from different labs; if you change providers, the first result at the new lab becomes the new baseline.

Diet, lifestyle and natural levers with evidence

What can move TgAb once the cause is known. Nothing here replaces finding the cause.

Selenium

Moderate evidence

A meta-analysis of 16 randomised trials found that 200 mcg of selenium a day lowered thyroid antibody levels in Hashimoto's thyroiditis, with the clearest effect on TPO antibodies; thyroglobulin antibodies fell in some trials (by around 20 to 30 percent at 3 to 6 months) but less consistently. Thyroid function, levothyroxine dose and symptoms were not clearly improved, and a Cochrane review judged the evidence insufficient for clinical benefit. Most likely to help when baseline selenium is low.

Keep total intake under 400 mcg a day; one large trial linked 200 mcg a day to a higher rate of type 2 diabetes. Not a treatment for thyroid cancer and does not change the need for thyroglobulin monitoring.

Vitamin D, if you are deficient

Preliminary evidence

Low vitamin D is more common in autoimmune thyroiditis than in controls, and small randomised trials (typically 1,000 to 4,000 IU a day for 3 to 6 months in deficient people) have reported falls in TPO and, in some, thyroglobulin antibody levels, with no clear change in TSH. Trials were short and did not test whether hypothyroidism was prevented. Correcting a 25-hydroxyvitamin D under 20 ng/mL is reasonable; high doses are not.

Doses above 4,000 IU a day without monitoring risk raised calcium; check a level first.

Avoid excess iodine

Moderate evidence

Iodine intake well above the 150 mcg a day adults need increases thyroid autoimmunity: a five-year comparison of three Chinese regions found higher rates of new autoimmune thyroiditis and subclinical hypothyroidism where intake was more than adequate or excessive. Kelp, bladderwrack and iodine drops supply many times the requirement; a normal diet with iodised salt supplies enough.

Do not restrict iodine in pregnancy, when the requirement rises to 220 to 290 mcg a day. After thyroid cancer treatment, follow your team's specific advice on iodine, which may include a low-iodine diet before radioiodine scans.

Celiac screening and a gluten-free diet if celiac disease is found

Preliminary evidence

Celiac disease affects 2 to 5 percent of people with autoimmune thyroid disease and often goes unrecognised; treating it improves levothyroxine absorption and general health. In a 6-month pilot study of 34 women with Hashimoto's without celiac disease, a gluten-free diet lowered thyroglobulin and TPO antibody levels modestly but did not change thyroid function, so the evidence for going gluten-free without celiac disease is weak.

Get tested for celiac disease before removing gluten; the tTG-IgA test and biopsy become unreliable once gluten is stopped.

When to see a clinician promptly

Positive antibodies with a TSH over 10 mIU/L or a low free T4 (overt hypothyroidism), or a suppressed TSH with symptoms of overactivity.
After thyroid cancer treatment: a rising thyroglobulin antibody level, a new neck lump, persistent hoarseness, or difficulty swallowing or breathing, all of which need prompt review and imaging.
Severe hypothyroid features: confusion, extreme drowsiness, a low body temperature or slow pulse, particularly in older adults; myxedema coma is an emergency.
Low TSH with a racing or irregular heartbeat, chest pain, fever or agitation: possible thyroid storm, needs emergency care.
Tingling around the mouth or in the fingers, or muscle cramps and spasms in the weeks after thyroid surgery, which can mean low calcium from parathyroid injury.
Positive antibodies and you are pregnant, trying to conceive or have had miscarriages, so that TSH can be monitored each trimester.

Frequently asked questions

What is a normal thyroglobulin antibody level?

Normal is below the cut-off printed on your report, and that cut-off varies enormously between assays: under 4 IU/mL on some, under 20 or 40 on others, and under 115 IU/mL on one widely used platform. A result below your lab's cut-off is negative. Because of this variation, never compare a value from one lab with a range quoted for another, and when changing labs treat the first new result as a fresh baseline.

What does a high thyroglobulin antibody mean?

In most people it means autoimmune thyroid disease, the same thing a positive TPO antibody means: Hashimoto's thyroiditis if TSH is high, Graves' disease if TSH is low (confirmed with TSH receptor antibodies), or autoimmune thyroiditis without thyroid dysfunction if TSH is normal. In someone treated for thyroid cancer it has a separate meaning: it makes the thyroglobulin test unreliable, and the antibody level is tracked over time instead.

What is the difference between thyroglobulin and thyroglobulin antibodies?

Thyroglobulin is the protein itself, made only by thyroid cells; after thyroid cancer surgery it is measured as a tumor marker, where an undetectable level (under about 0.2 ng/mL) means no thyroid tissue remains. Thyroglobulin antibodies are the immune system's antibodies against that protein. They are a marker of autoimmune thyroid disease, and in cancer follow-up they interfere with the thyroglobulin test, which is why both are always measured together.

Is a thyroglobulin antibody of 100, 500 or 1,000 high?

On nearly every assay all three are positive, and all mean the same thing: an autoimmune reaction against the thyroid. Higher values indicate more immune activity but not a worse-functioning thyroid; TSH and free T4 tell you that. After thyroid cancer treatment, what matters is not the level but whether it is falling (reassuring), stable, or rising by 50 percent or more between tests (prompts imaging).

Can thyroglobulin antibodies be high but TPO antibodies normal?

Yes, in roughly 3 to 5 percent of adults. Isolated TgAb positivity with a normal TSH carries only a small increase in the risk of future hypothyroidism, lower than TPO positivity, and is usually managed by rechecking TSH every year or so. It can also be a transient finding after viral or postpartum thyroiditis. In thyroid cancer follow-up the TPO result is irrelevant; only TgAb interferes with thyroglobulin.

Do thyroglobulin antibodies mean thyroid cancer?

No. The antibodies are a marker of thyroid autoimmunity, not of cancer, and about one in ten healthy adults has them. They are more common in people with thyroid cancer (20 to 25 percent) because the tumor or surrounding thyroiditis exposes the antigen, but the test is not used to diagnose cancer; nodules are assessed by ultrasound and, if needed, needle biopsy. After cancer treatment the antibody trend, not its presence, is what matters.

How long do thyroglobulin antibodies take to go away after thyroidectomy?

Once all thyroid tissue has been removed or ablated with radioiodine, antibodies fall with a half-life of about 10 weeks, but the immune memory fades slowly: in a study of patients who had complete removal of thyroid tissue, antibodies disappeared in all of them, with a median time of about three years. A steady fall over the first one to two years is expected; a plateau or rise is what prompts further investigation.

References

Thyroid antibodies. MedlinePlus, US National Library of Medicine (2023)View source
Hashimoto thyroiditis. Merck Manual Professional Version (2024)View source
Thyroid cancer. Mayo Clinic (2024)View source
Haugen BR, Alexander EK, Bible KC, et al.. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2016)
Spencer CA. Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). Journal of Clinical Endocrinology and Metabolism (2011)
Chiovato L, Latrofa F, Braverman LE, et al.. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine (2003)
Hollowell JG, Staehling NW, Flanders WD, et al.. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism (2002)
Vanderpump MP, Tunbridge WM, French JM, et al.. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology (1995)
Jonklaas J, Bianco AC, Bauer AJ, et al.. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid (2014)
Wichman J, Winther KH, Bonnema SJ, Hegedüs L. Selenium supplementation for Hashimoto's thyroiditis: a systematic review and meta-analysis. Thyroid (2016)
Teng W, Shan Z, Teng X, et al.. Effect of iodine intake on thyroid diseases in China. New England Journal of Medicine (2006)
Krysiak R, Szkróbka W, Okopień B. The effect of gluten-free diet on thyroid autoimmunity in drug-naïve women with Hashimoto's thyroiditis: a pilot study. Experimental and Clinical Endocrinology and Diabetes (2019)

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your TgAb result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my TgAb

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.